OncoTherapy Science, Inc. has entered into a license agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A. (SEPPIC) to grant the exclusive rights to manufacture and sell the compact automatic emulsion-preparing devices originally developed by OncoTherapy. Under the terms of the agreement: OncoTherapy grants SEPPIC the exclusive rights to manufacture and sell the compact automatic emulsion-preparing devices; OncoTherapy will provide necessary information for such manufacture and sale to SEPPIC, and cooperate with SEPPIC; and OncoTherapy will receive royalty based on the sales amount of such devices in consideration of the licenses under this agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26 JPY | -13.33% | +18.18% | +13.04% |
04-29 | Poland's Tusk calls prosecutor over potential Orlen scandal | RE |
04-22 | OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+13.04% | 45.58M | |
+8.17% | 114B | |
+9.79% | 104B | |
-1.83% | 22.57B | |
-11.28% | 22.5B | |
-10.39% | 17.95B | |
-41.90% | 16.48B | |
-14.02% | 15.82B | |
+3.78% | 13.55B | |
+28.81% | 10.99B |
- Stock Market
- Equities
- 4564 Stock
- News OncoTherapy Science, Inc.
- OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A